{"id":"W2151647473","doi":"10.1086/499364","title":"Pharmacogenetics of Plasma Efavirenz Exposure after Treatment Discontinuation: An Adult AIDS Clinical Trials Group Study","year":2006,"lang":"en","type":"article","venue":"Clinical Infectious Diseases","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":221,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Center for Research Resources; National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; University of California, San Diego; National Institute of Neurological Disorders and Stroke; University of Pittsburgh; University of Washington; Case Western Reserve University; University of Minnesota; Pfizer; Northwestern University; Biogen; University of Rochester; University of Miami; York University; Bristol-Myers Squibb; Quest Diagnostics; University of Pennsylvania; Gilead Sciences; Vanderbilt University; National Institutes of Health; Ohio State University; ACT Government; University of Southern California; Emory University; Brigham and Women's Hospital; GlaxoSmithKline","keywords":"Efavirenz; Discontinuation; Medicine; CYP2B6; Internal medicine; Interquartile range; Genotype; Gastroenterology; Pharmacogenetics; Pharmacokinetics; Population; Pharmacology; Viral load; Virology; Antiretroviral therapy; Human immunodeficiency virus (HIV); Biology; Genetics; Cytochrome P450; CYP3A4","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00670086,0.0007274331,0.001174333,0.0003260128,0.0004338397,0.001018689,0.0004364806,0.001078335,0.001919943],"category_scores_gemma":[0.00940324,0.0003254424,0.0008867169,0.0008594151,0.0004045482,0.000593825,0.0003421426,0.0009248473,0.000392059],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003039217,"about_ca_system_score_gemma":0.0005449638,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004927109,"about_ca_topic_score_gemma":0.0006804441,"domain_scores_codex":[0.9955337,0.003267681,0.0002874925,0.0004489535,0.0003018452,0.0001603886],"domain_scores_gemma":[0.9924343,0.002878995,0.002671048,0.0008567413,0.0005611888,0.0005978743],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2505703,0.003206068,0.6990254,0.0004805806,0.007929157,0.0005394382,0.0005266327,0.001077977,0.002262091,0.0003171638,0.002690586,0.03137465],"study_design_scores_gemma":[0.0701409,0.03299511,0.8822492,0.0001451551,0.005095833,0.001173485,0.0001777172,0.0024985,0.0005789449,0.0004083413,0.004471534,0.00006531523],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995878,0.001433227,0.0003849535,0.0001454,0.00002027285,0.0003034955,0.0007421235,0.00001185129,0.001080604],"genre_scores_gemma":[0.9971747,0.0004121,0.0005083211,0.0002272846,0.00007113136,0.0003860864,0.0008172917,0.000007446555,0.0003955654],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00670086,"threshold_uncertainty_score":0.03543794,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08505330597271046,"score_gpt":0.4501052160299698,"score_spread":0.3650519100572593,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}